Published in

American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 1(60), p. 296-300, 2016

DOI: 10.1128/aac.01462-15

Links

Tools

Export citation

Search in Google Scholar

In VivoSynergy of Amphotericin B plus Posaconazole in Murine Aspergillosis

Journal article published in 2015 by Adela Martin-Vicente, Javier Capilla, Josep Guarro ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

ABSTRACT Aspergillus fumigatus is the main mold causing invasive fungal infection that shows high mortality rates. Therapeutic failure and the increase in drug resistance make it necessary to explore alternative treatments for this infection. We have evaluated the efficacy of amphotericin B at 0.8 mg/kg or 0.3 mg/kg of body weight combined with 40 mg/kg of posaconazole against three A. fumigatus isolates in a murine model of disseminated infection. The combination of the polyene and the azole led to a greater increase in survival and a significantly greater reduction in tissue burden than monotherapies.